Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes
Get Live Data
1.10    0.00 (0.00%)
Bid:
1.00
Ask:
1.10
Spread: 0.10 (10.00%)
Market Cap: £25.80m
PXS Live PriceLast checked at - London Stock Exchange

Intraday Provexis Share Chart

AGM Statement

24 Aug 2011 07:00

RNS Number : 9007M
Provexis PLC
24 August 2011
 



24 August 2011

Provexis plc

 

AGM Statement

 

Provexis plc ("Provexis" or the "Company"), the life-science business that develops, licenses and markets scientifically-proven functional food, sports nutrition and medical food technologies, will hold its Annual General Meeting in Reading later today.

 

At the meeting Dawson Buck, the non-executive Chairman of the Company, will give the following update on developments:

 

 "The Company has made major progress over the past 18 months, specifically with the commercialisation of its lead technology Fruitflow and the recent acquisition of Science in Sport ("SiS").

 

Following the announcement of the long-term Alliance with DSM Nutritional Products ("DSM") in June 2010, DSM has made good progress in marketing Fruitflow to a broad range of global markets, attracting positive interest from a wide range of global, multinational and national brand owners in the functional food and dietary supplement sectors. The Alliance expects to see initial revenues from Fruitflow commence in the coming months and the Company looks forward to updating shareholders on this matter as and when appropriate.

 

The Company acquired SiS in June 2011. The Board are very pleased with the business and the opportunities it presents to the enlarged group. The Board strongly believe that through targeted investment SiS will achieve significant like for like revenue growth and margin improvement. As part of this investment the Directors expect to transfer production and distribution to a larger facility later in the year, in line with growth plans for the business. Defined marketing and selling strategies, together with new product launches and efficiencies from the supply chain, will underpin sales and profit growth in the business during 2012.

 

The SiS business presents the Company with a number of opportunities to bring new products to market to support 2012 growth; consequently the Board is currently reviewing the overall project pipeline for the Company in order to allocate resource and capital in the most effective way, in line with our growth targets.

 

We have a busy year ahead of us, with the main focus of the executive team being on delivering revenues from Fruitflow and growing the sales and profitability of the SiS business. We have sufficient resources to hand to deliver our targets and I look forward to a year of strong progress."

 

-ends-

 

For further information please contact:

 

Stephen Moon, Chief Executive

Provexis plc Tel: 01753 833177

 

Bobbie Hilliam Tel: 020 7071 4317

Evolution Securities

 

Haggie Financial LLP: Tel: 020 7417 8989

Matthew Longbottom/Peter Rigby matthew.longbottom@haggie.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMEXLFLFVFLBBB
Date   Source Headline
19th Dec 20069:54 amRNSInterim Results
3rd Nov 20067:00 amRNSSirco Distribution Gains
1st Nov 20067:01 amRNSRe Fruitflow Licence
29th Sep 200611:50 amRNSResult of AGM
29th Sep 20067:03 amRNSAGM Statement
11th Sep 200612:09 pmRNSAnnual Report and Accounts
10th Aug 200611:51 amRNSAdditional Listing
31st Jul 20067:01 amRNSSirco Distribution Gains
24th Jul 20067:03 amRNSDirectorate Change
24th Jul 20067:01 amRNSExclusivity Agreement
15th Jun 20067:07 amRNSFinal Results
6th Jun 200612:35 pmRNSIssue of Equity
16th May 20067:01 amRNSAJCN endorses Sirco
20th Apr 20067:01 amRNSChange to Sirco Listings
6th Apr 20067:01 amRNSTrading Update
9th Mar 20067:01 amRNSExpert Panel Approval
17th Jan 20067:00 amRNSDirector/PDMR Shareholding
9th Jan 20067:01 amRNSMajor Distribution Agreement
16th Dec 20057:00 amRNSProduct Launch
9th Dec 20057:00 amRNSDirectorate Change
23rd Nov 20057:02 amRNSInterim Results
16th Nov 20053:27 pmRNSNotice of Results
7th Nov 20057:01 amRNSAwarded Research Grant
3rd Nov 20057:00 amRNSUS Patent Awarded
5th Oct 20057:00 amRNSDisposal
12th Sep 20057:01 amRNSCollaboration Agreement
1st Aug 20057:01 amRNSProduct endorsement agreement
28th Jul 200512:31 pmRNSAnnual Report and Accounts
22nd Jul 20057:00 amRNSPreliminary Results
13th Jul 20059:57 amRNSDirector/PDMR Shareholding
24th Jun 20058:03 amRNSTrading on AIM
24th Jun 20058:00 amRNSRe Provexis Admission to AIM
20th Jun 200510:36 amRNSEGM Statement
6th Jun 20055:05 pmRNSSchedule 1 - Provexis plc
26th May 20057:02 amRNSProvexis - Reverse Takeover
26th May 20057:00 amRNSProposed acquisition
26th May 20057:00 amRNSRestoration - Nutrinnovator
18th Mar 20057:00 amRNSAcquisition Update
18th Feb 20058:52 amRNSProvexis Reverse Takeover
18th Feb 20058:40 amRNSAcquisition
18th Feb 20058:40 amRNSSuspension-Nutrinnovator Hld
18th Feb 20057:02 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.